5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | NEUTRAL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 12.52▲ | 12.53▼ | 12.53▼ | 12.52▲ | 12.36▲ |
MA10 | 12.53▲ | 12.53▼ | 12.54▼ | 12.41▲ | 12.19▲ |
MA20 | 12.53▲ | 12.54▼ | 12.53▼ | 12.33▲ | 12.10▲ |
MA50 | 12.54▼ | 12.48▲ | 12.41▲ | 12.10▲ | 13.11▼ |
MA100 | 12.49▲ | 12.37▲ | 12.34▲ | 12.16▲ | 12.93▼ |
MA200 | 12.38▲ | 12.26▲ | 12.20▲ | 12.95▼ | 12.96▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | -0.007▼ | -0.009▼ | 0.018▲ | 0.134▲ |
RSI | 50.200▲ | 58.229▲ | 64.201▲ | 69.927▲ | 52.802▲ |
STOCH | 10.000▼ | 12.778▼ | 27.222 | 93.737▲ | 91.473▲ |
WILL %R | -40.000 | -66.667 | -60.000 | -10.000▲ | -2.116▲ |
CCI | -62.222 | -96.078 | -73.375 | 108.738▲ | 123.965▲ |
Wednesday, June 25, 2025 01:00 PM
NEW YORK, June 17, 2025--KKR Income Opportunities Fund (the "Fund") (NYSE: KIO) today announced its monthly distributions of $0.1215 per common share, payable on the dates below. Based on the Fund ...
|
Tuesday, June 03, 2025 12:01 AM
Encinitas, California--(Newsfile Corp. - June 3, 2025) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced it has granted Senju Pharmaceutical Co., Ltd. (Senju ...
|
Monday, April 28, 2025 05:00 PM
Read KKR Income Opportunities Fund (NYSE:KIO) Stock Price Passes Below 200-Day Moving Average – Here’s What Happened at ETF Daily News ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/07/25 | 12.55 | 12.55 | 12.51 | 12.54 | 0 |
30/06/25 | 12.53 | 12.58 | 12.53 | 12.56 | 0 |
27/06/25 | 12.50 | 12.54 | 12.49 | 12.53 | 0 |
26/06/25 | 12.48 | 12.52 | 12.42 | 12.52 | 0 |
25/06/25 | 12.40 | 12.49 | 12.39 | 12.46 | 0 |
24/06/25 | 12.40 | 12.40 | 12.32 | 12.39 | 0 |
23/06/25 | 12.33 | 12.34 | 12.30 | 12.32 | 0 |
20/06/25 | 12.30 | 12.32 | 12.29 | 12.30 | 0 |
18/06/25 | 12.25 | 12.28 | 12.23 | 12.27 | 122,247 |
17/06/25 | 12.22 | 12.25 | 12.18 | 12.23 | 177,763 |
|
|
||||
|
|
||||
|
|